Investing

FDA openness to Bayesian methods noted by BioStem Technologies

POMPANO BEACH, Fla. - BioStem Technologies, Inc. (OTC:BSEM), a microcap company with a market capitalization of $90.22 million, highlighted recent statements from FDA leadership indicating greater ...
Morningstar

Professor Sarfaraz Niazi's Scientific Framework Adopted as FDA Modernizes Clinical Trial Evaluation Through Bayesian Methods

WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
Becker's Hospital Review

FDA proposes new framework for clinical drug trial designs

The FDA has released new draft guidance outlining the use of Bayesian methodologies in clinical trials for drugs and biologics. The guidance is intended to help sponsors apply modern statistical ...
Science Daily

AI unravels the hidden communication of gut microbes

Scientists have turned to advanced AI to decode the intricate ecosystem of gut bacteria and their chemical signals. Using a Bayesian neural network called VBayesMM, researchers can now identify ...
News Medical

Bayesian neural networks advance understanding of gut microbe metabolism

Gut bacteria are known to be a key factor in many health-related concerns. However, the number and variety of them is vast, as are the ways in which they interact with the body's chemistry and each ...
JSTOR Daily

Learning from a lot: Empirical Bayes for high-dimensional model-based prediction

Empirical Bayes is a versatile approach to “learn from a lot” in two ways: first, from a large number of variables and, second, from a potentially large amount of prior information, for example, ...
IEEE

Toward Variational Structural Learning of Bayesian Networks

Abstract: This study presents a novel variational framework for structural learning in Bayesian networks (BNs), addressing the key limitation of existing Bayesian methods: their lack of scalability to ...